2017_SBRT_Course Book

Patient presentation

• 65 year old female • Performance status 90% • Comorbidities: • No relevant until diagnosis of cancer • Paraneoplastic syndroms: • Anemia • Depression after diagnosis of cancer

07.09.17 ESTRO SBRT COURSE 2017 - Matthias Guckenberger

3

/

Initial staging & histopathology

Primary

Hilar LN Adrenal

Ø NSCLC cT2 cN1 cM1 (adrenal), Adeno Carcinoma Ø Synchronous oligo-metastatic stage IV NSCLC Ø EGFR, BRAF, KRAS, ERBB2, ALK, ROS1 negative 08/2015

07.09.17 ESTRO SBRT COURSE 2017 - Matthias Guckenberger

4

/

Made with FlippingBook Annual report